Global Wealth Strategies & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-322
Closed -$158K 433
2026
Q1
$158K Buy
+322
New +$175K 0.04% 94
2025
Q1
Sell
-6
Closed -$3.12K 512
2024
Q4
$3.12K Hold
6
﹤0.01% 298
2024
Q3
$3.71K Hold
6
﹤0.01% 256
2024
Q2
$3.32K Hold
6
﹤0.01% 241
2024
Q1
$3.49K Hold
6
﹤0.01% 243
2023
Q4
$3.19K Hold
6
﹤0.01% 230
2023
Q3
$3.04K Hold
6
﹤0.01% 233
2023
Q2
$3.13K Hold
6
﹤0.01% 228
2023
Q1
$3.46K Hold
6
﹤0.01% 228
2022
Q4
$3.3K Buy
+6
New +$3.18K ﹤0.01% 238

Other funds holding TMO

Global Wealth Strategies & Associates's TMO Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 322 shares — an estimated $158K sold.

Global Wealth Strategies & Associates first reported a position in TMO in Q4 2022 and held it in 10 quarters. The position peaked at $158K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 322 Thermo Fisher Scientific shares in Q2 2026, an estimated $158K.
  • Global Wealth Strategies & Associates first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 10 quarters.
  • Global Wealth Strategies & Associates's Thermo Fisher Scientific position peaked at $158K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.